First, there are many other confounders that we should but can not adjust since they are not measured in the ARIC study at visit 1, such as many inflammatory markers (e.g. BNP, hsCRP) which will affect the atherosclerosis progress and ends up in impacting stroke. The gene discussed is NPPB; the disease is atherosclerosis.